NEW
Stock Screener with Intrinsic Value
United Therapeutics Corporation (UTHR)
Last Price$365.0(0.4%)
Market Cap$16.2B
Relative value
$421.8
Undervalued (Relative Value)
15.6%
NTM P/E
10.9x
Peer set median: 12.6x
1Y Fwd EV/EBITDA
10.7x
Peer set median: 9.1x
Stock quality
8/10
Great
UTHR Relative Value & Intrinsic Value
Crunching data... Almost there!
Best stock ideas on the market right now
With Value Sense, you can find undervalued stocks list with intrinsic value. Discover more stock market investment ideas.
UTHR Valuation Multiples comparison vs Peer Set
Crunching data... Almost there!
UTHR Valuation multiples overview
Crunching data... Almost there!
UTHR Valuation multiples history vs. Peer set
Crunching data... Almost there!
Explore more intrinsic value tools hub for UTHR
DCF value calculator
Peter Lynch Fair Value
Earnings Power Value
Intrinsic Value
Reverse DCF
Margin of safety
Peter Lynch charts
Earnings growth model
Ben Graham Fair Value
Discount rate
Loved by
investors
worldwide
investors
worldwide
10K+
Investors
use our platform
#1
Top value investing hub
with all necessary tools
1K+
Experienced investors
in our community
4.9
Average rating across
all rating platforms
FAQ
What is United Therapeutics Corporation relative value?
As of Jan 10, 2025, Apple Relative Value is $421.8. This suggests it may be overvalued by 15.6% compared to its current price of around $365.0.
What is United Therapeutics Corporation DCF (discounted cash flow) valuation?
As of Jan 10, 2025, United Therapeutics Corporation's Discounted Cash Flow (DCF) valuation estimates its share price at $428.1. This suggests it may be overvalued by 17.3% to its current price of around $365.0, using a discount rate of 7.8% and terminal growth rate of 3.0%.
What is United Therapeutics Corporation intrinsic value?
As of Jan 10, 2025, Apple Intrinsic Value is $421.5. This suggests it may be undervalued by 15.5% compared to its current price of around $365.0.